Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7Neoplasms 2Weight Loss 1Prostatic Neoplasms 1Polyps 1Osteoporosis 1Myocardial Ischemia 1Myocardial Infarction 1Metabolic Syndrome 1Heart Diseases 1Diabetes Mellitus 1Depression 1Coronary Disease 1Colonic Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Bone Diseases 1Body Weight Changes 1Angina, Unstable 1Adenoma 1

Interventions

Exercise 4Walking 2Memantine 2Donepezil 2beta Carotene 1Vitamin E 1Ultraviolet Therapy 1Time 1Tai Ji 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Sirolimus 1Riluzole 1Rehabilitation, Vocational 1Referral and Consultation 1Ramipril 1Radiotherapy, Intensity-Modulated 1Quality of Life 1Population Groups 1Pioglitazone 1Palliative Care 1Neuropsychological Tests 1Mindfulness-Based Stress Reduction 1Methods 1Interviews as Topic 1Ibuprofen 1Hormones 1Hematologic Tests 1Geritol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cognitive Dysfunction × Diet, Fat-Restricted × Clear all
NCT00924937 2021-06-03

CORDIOPREV

Hospital Universitario Reina Sofia de Cordoba

Phase NA Completed
1,002 enrolled

Angina, Unstable, Diabetes Mellitus, Myocardial Infarction, Neoplasms, Metabolic Syndrome, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡